Claire Mazumdar serves as Executive at Bicara Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Claire Mazumdar has executed 9 insider transactions totaling $1.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 16, 2025 involved exercising options for 29,500 shares valued at $160.8K.
Claire Mazumdar currently holds 339,392 shares of Bicara Therapeutics Inc. (BCAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Claire Mazumdar has been a net seller of BCAX stock. They have purchased $0 and sold $1.7M worth of shares.
Claire Mazumdar's most recent insider trade was on Dec 16, 2025, when they sold 29,500 shares at $5.45 per share.
Get notified when new Form 4 filings are submitted
| 41,163 |
| $3.79 |
| Discretionary |
| Nov 24, 2025 | BCAX | $776.3K | Sale | 41,163 | $18.86 | Discretionary |
| Oct 16, 2025 | BCAX | $91.4K | Option Exercise | 24,103 | $3.79 | Discretionary |
| Oct 16, 2025 | BCAX | $453.9K | Sale | 24,103 | $18.83 | Discretionary |
| Oct 15, 2025 | BCAX | $250.4K | Sale | 13,289 | $18.84 | Discretionary |
| Oct 15, 2025 | BCAX | $50.4K | Option Exercise | 13,289 | $3.79 | Discretionary |
| Oct 13, 2025 | BCAX | $43.4K | Option Exercise | 11,445 | $3.79 | Discretionary |
| Oct 13, 2025 | BCAX | $216.5K | Sale | 11,445 | $18.92 | Discretionary |